DMFs are confidential, proprietary assets that present to the FDA the formulae, processes, test methodology, and other data relevant to the manufacture of products used in the composition, packaging and processing of pharmaceuticals or biologics. Indian firms accounted for 104 out of the 251 new DMFs made in the US in April-June 2006, compared with 74 out of 213 a year ago.
Indian drug firms file most DMFs in U.S.
Indian pharma companies filed the largest number of drug master filings (DMFs) with the FDA in the April-June 2006 quarter, accounting for almost 42 percent of filings.
May 31, 2007
Machinery Basics
New ebook focused on cartoning equipment
Read about the various types of cartoning equipment, how to select the right one, and common pitfalls to avoid. Plus, read equipment advice from CPGs for ultimate cartoning success.
Read More
